Oxymatrine and Cisplatin Synergistically Enhance Anti-Tumor Immunity of CD8+ T Cells in Non-Small Cell Lung Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

FEN1 Promotes Tumor Progression and Confers Cisplatin Resistance in Non-Small-Cell Lung Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2017English

Modulating Immunometabolism of Tumor Specific CD8 T Cells to Enhance T Cell Based Therapy for Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Antibodies to Costimulatory Receptor 4-1bb Enhance Anti-Tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function

Immunity
Infectious DiseasesAllergyImmunology
2018English

Tumor-Induced CD8+ T-Cell Dysfunction in Lung Cancer Patients

Clinical and Developmental Immunology
2012English

Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2015English

Autophagy Regulation of Metabolism Is Required for CD8+ T Cell Anti-Tumor Immunity

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Tumor Evolution in Non-Small-Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2018English

Cisplatin, Vinblastine, and Bleomycin in Inoperable Non-Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1985English

Bioenergetics of Acquired Cisplatin Resistant H1299 Non-Small Cell Lung Cancer and P31 Mesothelioma Cells

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy